Hepatitis C Information Central

The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatments here at Hepatitis-Central.com.

Hep C information
Free Newsletter
Hepatitis C Newsletter
We value your privacy. We will not rent your email to anyone.
HEPATITIS NEWS
The top stories compiled from over 5,500 sources, updated every 15 minutes

Hepatitis B, Chronic: Entecavir (NICE)
You must be a registered user to access the content and receive email bulletins from Healthcare Republic. If you have a paid subscription to MIMS or MIMS for Nurses, please activate your subscription. Otherwise, complete the free registration by choosing

Genelabs, NHRI collaborate on hepatitis C drug candidates
REDWOOD CITY, Calif.- has entered into a collaborative research agreement with the to discover and develop compounds that target the hepatitis C virus (HCV). HCV drug candidates will be developed using Genelabs' lead compounds on an existing target the

UPDATES AND COMMENTARY RSS Feed

Hep C Treatment: Comparing the Pegylated Interferons
Learn about the facts on pegylated interferon alfa-2a and pegylated interferon alfa-2b, the standard treatment for chronic Hepatitis C. Comparing and contrasting the pegylated interferons may help better explain a physician’s preference or indifference between the two when treating their...

Vertex's Advanced Trial Could Change HCV Treatment
Hundreds of non-responders to interferon-ribavirin combination therapy will be enrolled in a late stage clinical trial for Vertex's telaprevir....

Silymarin Improves Quality of Life During Hepatitis C Treatment
Although a large-scale study concluded long-term interferon therapy to be ineffectual for Hepatitis C management, it demonstrated improvements in quality of life for participants supplementing with silymarin....

Association of Diabetes Mellitus and Chronic Hepatitis C Virus Infection

table  3.   Characteristics of Diabetic Cohort Assessed by EIA II for Anti-HCV Status


Clinical Features Anti-HCV Status
P
Negative (n = 569) Positive (n = 25)

Mean age (yr) (SD) 62 (14) 59 (15) .37*
Sex (%)
  Female 260 (46) 13 (52) .54
  Male 309 (54) 12 (48)
Race origin (%)dagger gif
  White 371 (70) 12 (50) .26
  African 149 (26) 11 (46)
  Asian 14 (3) 1 (4)
  Hispanic 4 (1) 0 (0)
Liver function tests (%)
  None available 32 (6) 1 (4) <.0001
  Always normal 335 (59) 8 (32)
  Intermittently abnormal 173 (30) 8 (32)
  Always abnormal 29 (5) 8 (32)

* t test.
dagger gif The discrepancy in numbers compared with total population size is due to records without data on race.

Return To Article

  Hep C information

Information at this website is for educational purposes only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.

©1994-2008 Hepatitis-Central.com
Updated 27 Aug 2008